What is INTS's dilution risk score?

INTS has a latest available DilutionScore record of 39/100, categorized as medium dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for INTS, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for INTS?

DilutionWatch tracks 25 SEC filing types for INTS including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect INTS shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For INTS, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for INTS tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for INTS. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

INTS Dilution Risk Score: 39/100 (MEDIUM)

Score Breakdown

📋 Offering Ability

60

💰 Cash Runway

10

📊 Float Risk

30

⚠️ Warrant Exposure

40

🔄 Convertible Debt

15

Dilution Forecast

☀️

Clear

No significant dilution signals

model est. 0%

No significant dilution signals detected for INTS.

🔔 Track INTS — Get forecast alerts →

Market Data

Market Cap$11.87M

Shares Outstanding3.26M

Float2.47M

Cash$18.48M

DebtN/A

Short InterestN/A

Institutional Holdings

QoQ: ↓ 97.5% shares (2026Q1 vs prior)

3 institutional holders · 111.0K shares

#1 Corient Private Wealth LLC 100.0K shares

#2 World Investment Advisors 10.0K shares

#3 MORGAN STANLEY 1.0K shares

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest68.4K

Days to Cover2.9

% of Float2.8%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2025-12-31

xbrl XBRL WARRANT 2023-12-31

4 INSIDER TRANSACTION 2026-01-05

Full SEC filing analysis available with free account →

Recent News

Soft Tissue Sarcoma Market Set for Significant Growth at a CAGR of 7.9% During t PR Newswire · Jul 15

Intensity Therapeutics Resumes Dosing in Phase 2 Trial for Investigational Cance MT Newswires · Jul 15

Intensity Therapeutics, Inc. Restarts Patient Treatment in the Randomized, Presu PR Newswire · Jul 15

Factual INTS Dilution Snapshot

Intensity Therapeutics, Inc. (INTS) has a DilutionScore of 39/100, rated Medium dilution risk. Score date: August 28, 2026.

Recent SEC activity tracked for INTS: 4 on 2026-01-05; 4 on 2026-01-05; xbrl on 2025-12-31.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.